Here we provide a selection of scientific publications related to IOZK immunotherapy. You can use the filters to make a selection according to tumor types and methods, or enter search terms.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-02-01 / HBPD INT 2006 Feb;5(1):22-7https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-02-01 / HBPD INT 2006 Feb;5(1):22-72006-02-01 00:00:002019-02-15 09:17:43Recent advances in heat shock protein-based cancer vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-02-01 / Int. J. Cancer 2006 Feb;118(3):658-67https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-02-01 / Int. J. Cancer 2006 Feb;118(3):658-672006-02-01 00:00:002020-06-23 09:36:57A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-02-01 / Clin. Cancer Res. 2006 Feb;12(3 Pt 1):878-87https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-02-01 / Clin. Cancer Res. 2006 Feb;12(3 Pt 1):878-872006-02-01 00:00:002019-02-15 08:48:35Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-21 / World J. Gastroenterol. 2006 Jan;12(3):473-8https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-21 / World J. Gastroenterol. 2006 Jan;12(3):473-82006-01-21 00:00:002019-02-15 08:38:17Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-18 / Vaccine 2006 Feb;24(7):887-96https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-18 / Vaccine 2006 Feb;24(7):887-962006-01-18 00:00:002019-02-15 08:37:42Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-17 / Ann. Oncol. 2006 Apr;17(4):563-70https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-17 / Ann. Oncol. 2006 Apr;17(4):563-702006-01-17 00:00:002019-02-15 09:19:51Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-05 / Breast Cancer Res. 2006;8(1):101https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-05 / Breast Cancer Res. 2006;8(1):1012006-01-05 00:00:002019-02-15 08:44:41Dendritic cell defects in patients with cancer: mechanisms and significance
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / Cytotherapy 2006;8(3):277-89https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / Cytotherapy 2006;8(3):277-892006-01-01 00:00:002019-02-15 08:51:01Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / J. Immunother. 2006 Jan-Feb;29(1):67-77https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / J. Immunother. 2006 Jan-Feb;29(1):67-772006-01-01 00:00:002006-01-01 00:00:00Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon-alpha as potent immune enhancers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / Surg. Today 2006;36(6):559-62https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / Surg. Today 2006;36(6):559-622006-01-01 00:00:002019-02-15 08:36:22Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / J. Gen. Virol. 2006 Jan;87(Pt 1):1-10https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / J. Gen. Virol. 2006 Jan;87(Pt 1):1-102006-01-01 00:00:002019-02-15 08:37:43Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / Cytotherapy 2006;8(4):318-26https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / Cytotherapy 2006;8(4):318-262006-01-01 00:00:002019-02-15 08:45:56Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors
Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens
Novel immunotherapeutic approaches to glioma
Recent advances in heat shock protein-based cancer vaccines
A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo
Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70
Immunization with antigen-pulsed dendritic cells significantly improves the immune response to weak self-antigens
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection
Dendritic cell defects in patients with cancer: mechanisms and significance
Immunotherapy for prostate cancer
Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma
Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation
Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon-alpha as potent immune enhancers
Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case
Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3
Genetically modified dendritic cells for therapeutic immunity
Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors
Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination